Baxter International Inc. [NYSE:BAX] shares are showing an active tape with a current price of $78.82 on Thursday.
Baxter International Inc. is in the Healthcare sector under the Medical Instruments & Supplies industry. This week, we are watching the stock hit price per sales of 3.46 with an earning per share of 1.40.
For the year, the stock is trading -5.88% and the five-day change stands at -4.40%. As a point of reference, the S&P 500 is trading 0.38% YTD.
Wait and see
Holding a Market Cap of $39.53 billion, Baxter International Inc. has seen a trading range over the last year of $69.10-$95.19.
For the last five days, BAX is down from its last closing price. The average shares trading hands each day is 3.13M, with average 10-day volume coming in at 3.38 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for BAX. When we apply the Elder Force Index to Baxter International Inc., we are seeing an Elder Force Indicator number of 98618.16.
The recent performance of the stock is another area that can tell traders how to proceed. BAX is presenting an interesting case. This can be seen in the Forward P/E ratio, which currently stands at 21.37. Moreover, the company’s enterprise value has gone from $46.83B to $43.90B quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, BAX made a profit of 1.04 billion. Baxter International Inc. also saw quarter revenue growth year over year of 2.37%. In addition, the company has operating cash flow of $2.18 billion.
Looking at popular technical indicators, the company’s 5-day moving average is 79.06 compared to the 50-day moving average of 82.93. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. BAX currently holds a 9-day RSI of 34.66%, while 100-day RSI stands at 47.62%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. BAX’s 9-day MACD is -1.64 and the company’s 100-day MACD stands at -6.53.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 0.13% by insiders and 87.48% by institutions. Regarding institutional holdings, Blackrock Inc. owns 8.80%, while the second top holder, Vanguard Group, Inc. (The), currently owns 7.90%.
Over the last six months, insiders have sold 310 with the most recent transaction from FORSYTH JOHN D, Director, with a sell at price 83.59 per share.
Overall, the recommended rating for BAX is Moderate Buy. Currently, the company has 16 analysts watching the stock, and the average quarterly earnings estimate is 0.72. Quarterly revenue estimates are averaging 2.83B with the high estimate reaching 2.89B and the low at 2.77B.
To review, the current 1-year target estimate is sitting at 96.25, while the current price 78.82. Based on this, we expect the stock to rise considering the aforementioned fundamentals.